tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Caroline Palomeque, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).
Analyst Caroline Palomeque, carries an average stock price target met ratio of 21.25% that have a potential upside of 44.06% achieved within 519 days. Previously, Caroline Palomeque worked at MAXIM GROUP.
Caroline Palomeque’s has documented 33 price targets and ratings displayed on 8 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 15-Oct-2026.
Analyst best performing recommendations are on ASND (ASCENDIS PHARMA AS).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Nov-2015
$24
$21.38 (816.03%)
$24
6 months 29 days ago
(31-Mar-2026)
5/13 (38.46%)
$20.93 (681.76%)
1510
Buy Since 16-Mar-2020
8 months 20 days ago
(10-Feb-2026)
3/17 (17.65%)
$32.22 (329.45%)
204
Buy Since 29-Jul-2021
$15
1 years 6 days ago
(24-Oct-2025)
0/9 (0%)
$8.18 (119.94%)
Buy Since 16-May-2018
$40
$38.67 (2907.52%)
$40
3 years 4 months 15 days ago
(15-Jun-2023)
1/5 (20%)
$31.17 (353.00%)
904
Buy Since 23-Sep-2021
$28
$26.67 (2005.26%)
$35
3 years 8 months 21 days ago
(09-Feb-2023)
0/4 (0%)
$17.59 (168.97%)
Which stock is Caroline Palomeque most bullish on?
